Intraperitoneal Chemotherapy of Ovarian Cancer: A Review, With a Focus on Practical Aspects of Treatment
Author:
Affiliation:
1. From The University of Texas M.D. Anderson Cancer Center, Houston, TX; and the Section of Gynecologic Oncology, the University of Oklahoma, Health Sciences Center, Oklahoma City, OK
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2005.05.2456
Reference40 articles.
1. Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer
2. Phase III Trial of Standard-Dose Intravenous Cisplatin Plus Paclitaxel Versus Moderately High-Dose Carboplatin Followed by Intravenous Paclitaxel and Intraperitoneal Cisplatin in Small-Volume Stage III Ovarian Carcinoma: An Intergroup Study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group
3. Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
4. Dedrick RL, Myers CE, Bungay PM, et al: Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep 62:1,1978-9,
5. Intraperitoneal therapy for treatment of malignant disease principally confined to the peritoneal cavity
Cited by 150 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Intraperitoneal and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Ovarian Cancer;Current Treatment Options in Oncology;2024-01-04
2. Intraperitoneal Chemotherapy;Nolph and Gokal's Textbook of Peritoneal Dialysis;2023
3. Locoregional delivery of CAR-T cells in the clinic;Pharmacological Research;2022-08
4. Multiple isolated ovarian cancer recurrences in the cervix and vagina after supracervical hysterectomy: A case report;Gynecologic Oncology Reports;2022-06
5. Treatment of Advanced-Stage Ovarian Cancer;Advances in Diagnosis and Management of Ovarian Cancer;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3